201 related articles for article (PubMed ID: 10660154)
1. Analysis of effector CD4 (OX-40+) and CD8 (CD45RA+CD27-) T lymphocytes in active multiple sclerosis.
Hintzen RQ; Pot K; Paty D; Oger J
Acta Neurol Scand; 2000 Jan; 101(1):57-60. PubMed ID: 10660154
[TBL] [Abstract][Full Text] [Related]
2. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
Killestein J; Den Drijver BF; Van der Graaff WL; Uitdehaag BM; Polman CH; Van Lier RA
Mult Scler; 2001 Jun; 7(3):145-50. PubMed ID: 11475436
[TBL] [Abstract][Full Text] [Related]
3. Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controls.
Haegele KF; Stueckle CA; Malin JP; Sindern E
J Neuroimmunol; 2007 Feb; 183(1-2):168-74. PubMed ID: 17084910
[TBL] [Abstract][Full Text] [Related]
4. Increased CD8+ central memory T cells in patients with multiple sclerosis.
Liu GZ; Fang LB; Hjelmström P; Gao XG
Mult Scler; 2007 Mar; 13(2):149-55. PubMed ID: 17439879
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood T lymphocyte subsets in children with congenital asplenia.
Motkowski R; Michalkiewicz J; Mikoluc B; Smolka-Afifi D; Pietrucha B; Kubiszewska I; Piotrowska-Jastrzebska J; Bernatowska E
Hum Immunol; 2012 Nov; 73(11):1091-7. PubMed ID: 22902394
[TBL] [Abstract][Full Text] [Related]
6. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
Zafranskaya M; Oschmann P; Engel R; Weishaupt A; van Noort JM; Jomaa H; Eberl M
Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Pender MP; Csurhes PA; Pfluger CM; Burrows SR
Mult Scler; 2014 Dec; 20(14):1825-32. PubMed ID: 24842963
[TBL] [Abstract][Full Text] [Related]
8. CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls.
Vrethem M; Dahle C; Ekerfelt C; Forsberg P; Danielsson O; Ernerudh J
Acta Neurol Scand; 1998 Apr; 97(4):215-20. PubMed ID: 9576634
[TBL] [Abstract][Full Text] [Related]
9. Type 1 immune response in progressive multiple sclerosis.
Frisullo G; Plantone D; Marti A; Iorio R; Damato V; Nociti V; Patanella AK; Bianco A; Batocchi AP
J Neuroimmunol; 2012 Aug; 249(1-2):112-6. PubMed ID: 22613700
[TBL] [Abstract][Full Text] [Related]
10. Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis.
Mikulkova Z; Praksova P; Stourac P; Bednarik J; Strajtova L; Pacasova R; Belobradkova J; Dite P; Michalek J
Cell Immunol; 2010; 262(2):75-9. PubMed ID: 20219185
[TBL] [Abstract][Full Text] [Related]
11. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.
Jilek S; Schluep M; Rossetti AO; Guignard L; Le Goff G; Pantaleo G; Du Pasquier RA
Clin Immunol; 2007 Apr; 123(1):105-13. PubMed ID: 17188575
[TBL] [Abstract][Full Text] [Related]
12. Circulating CD8+CD56-perforin+ T cells are increased in multiple sclerosis patients.
Giovanni F; Domenico P; Alessandro M; Raffaele I; Viviana N; Katia PA; Paola BA
J Neuroimmunol; 2011 Dec; 240-241():137-41. PubMed ID: 22001684
[TBL] [Abstract][Full Text] [Related]
13. Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapse.
Aristimuño C; Navarro J; de Andrés C; Martínez-Ginés L; Giménez-Roldán S; Fernández-Cruz E; Sánchez-Ramón S
J Neuroimmunol; 2008 Nov; 204(1-2):131-5. PubMed ID: 18835045
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of effector memory CD8+ T cells in nasal polyps.
Pant H; Hughes A; Miljkovic D; Schembri M; Wormald P; Macardle P; Grose R; Zola H; Krumbiegel D
Am J Rhinol Allergy; 2013; 27(5):e117-26. PubMed ID: 24119592
[TBL] [Abstract][Full Text] [Related]
15. CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment.
Frisullo G; Iorio R; Plantone D; Marti A; Nociti V; Patanella AK; Batocchi AP
Mult Scler; 2011 May; 17(5):556-66. PubMed ID: 21177324
[TBL] [Abstract][Full Text] [Related]
16. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL
Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679
[TBL] [Abstract][Full Text] [Related]
17. Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.
Malhotra S; Villar LM; Costa C; Midaglia L; Cubedo M; Medina S; Fissolo N; Río J; Castilló J; Álvarez-Cermeño JC; Sánchez A; Montalban X; Comabella M
J Neuroinflammation; 2018 Oct; 15(1):296. PubMed ID: 30367633
[TBL] [Abstract][Full Text] [Related]
18. CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients.
Frisullo G; Nociti V; Iorio R; Plantone D; Patanella AK; Tonali PA; Batocchi AP
Hum Immunol; 2010 May; 71(5):437-41. PubMed ID: 20138197
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.
Teniente-Serra A; Grau-López L; Mansilla MJ; Fernández-Sanmartín M; Ester Condins A; Ramo-Tello C; Martínez-Cáceres E
Autoimmunity; 2016 Jun; 49(4):219-28. PubMed ID: 26829210
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CD4+ and CD8+ T Cell Subsets and Interferon Regulatory Factor 4 (IRF4) in MS Patients Treated with Fingolimod (FTY-720): A Follow-up Study.
Laribi B; Sahraian MA; Shekarabi M; Emamnejad R; Marzban M; Sadaghiani S; Izad M
Iran J Allergy Asthma Immunol; 2018 Aug; 17(4):346-360. PubMed ID: 30537798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
